Movatterモバイル変換


[0]ホーム

URL:


CN117603064B - Preparation method and intermediate of tri (hydroxyalkyl) methylamine - Google Patents

Preparation method and intermediate of tri (hydroxyalkyl) methylamine

Info

Publication number
CN117603064B
CN117603064BCN202311483348.6ACN202311483348ACN117603064BCN 117603064 BCN117603064 BCN 117603064BCN 202311483348 ACN202311483348 ACN 202311483348ACN 117603064 BCN117603064 BCN 117603064B
Authority
CN
China
Prior art keywords
compound
hydroxyalkyl
tri
preparation
methylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202311483348.6A
Other languages
Chinese (zh)
Other versions
CN117603064A (en
Inventor
陆茜
匡逸
汪海明
陆学友
沈国军
张婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Lingkai Technology Co ltd
Shanghai Linkchem Technology Co ltd
Original Assignee
Shanghai Lingkai Technology Co ltd
Shanghai Linkchem Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Lingkai Technology Co ltd, Shanghai Linkchem Technology Co ltdfiledCriticalShanghai Lingkai Technology Co ltd
Priority to CN202311483348.6ApriorityCriticalpatent/CN117603064B/en
Publication of CN117603064ApublicationCriticalpatent/CN117603064A/en
Application grantedgrantedCritical
Publication of CN117603064BpublicationCriticalpatent/CN117603064B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Landscapes

Abstract

The invention discloses a preparation method of tri (hydroxyalkyl) methylamine and an intermediate thereof, belonging to the field of organic synthesis. The invention provides a novel intermediate compound 4 for synthesizing tri (hydroxyalkyl) methyl amine, which is reacted with ozone and a reducing agent in sequence to obtain a novel intermediate compound 5, and then amino deprotection is carried out to obtain the target substance tri (hydroxyalkyl) methyl amine shown in a formula 6. The method is simpler, is more suitable for industrialization, and can obtain a series of tri (hydroxyalkyl) methyl amine by only changing the carbon chain length of the raw material.

Description

Preparation method and intermediate of tri (hydroxyalkyl) methylamine
Technical Field
The invention relates to the field of organic synthesis, in particular to a preparation method of tri (hydroxyalkyl) methylamine and an intermediate thereof.
Background
Tri (hydroxyalkyl) methylamine refers to a series of compounds including tri (hydroxymethyl) methylamine, tri (2-hydroxyethyl) methylamine, tri (3-hydroxypropyl) methylamine. Most of the series of compounds have similar chemical properties and have wide application prospect.
According to literature reports, tris (hydroxyalkyl) methylamines can be used to prepare buffer solutions with acidic reagents such as hydrochloric acid (e.g. journal literature Li D,Chen R,Zhu X,et al.Light fueled mixing in open surface droplet microfluidics for rapid probe preparation.[J].Physical chemistry chemical physics,2021,23(46):26356-26365.), can also be salified with active substances bearing carboxylic acid groups to give new crystalline forms of some drugs (e.g. patent literature US 20110230524).
In the prior art, george R.Newkome et al (George R.Newkome,Charles N.Moorefield,et A Convenient Synthesis of"Bis-homotris":4-Amino-4-[1-(3-hydroxypropyl)]-1,7-heptanediol and 1-Azoniapropellane.[J].J.Org.Chem.1988,53,5552-5554.) report a process that can be used to prepare tris (3-hydroxypropyl) methylamine, the specific reaction scheme is as follows:
from the above formula, it is known that since the starting material is acrylonitrile, it cannot be used for preparing tris (hydroxymethyl) methylamine or tris (2-hydroxyethyl) methylamine, is not universal, and it is also described that the first reaction step is strongly exothermic, and thus is not suitable for industrial production.
D.W.Moire et al (CN 104254516A) report a process for preparing tri (hydroxymethyl) methylamine by reacting formaldehyde with nitromethane as starting materials to give tri (hydroxymethyl) nitromethane and reducing the nitro group to give tri (hydroxymethyl) methylamine. However, this approach is limited to the preparation of tris (hydroxymethyl) methylamine, and if an aldehyde with a longer carbon chain is used instead of formaldehyde (such as acetaldehyde), the result is a product with the hydroxyl group at the beta position of the nitro group, rather than the alkyl end position.
Disclosure of Invention
The present invention has been made to solve the above-described problems, and an object of the present invention is to provide a process for producing tri (hydroxyalkyl) methylamines which can be used for producing a wider variety of tri (hydroxyalkyl) methylamines, and an intermediate for synthesizing tri (hydroxyalkyl) methylamines using the process.
The invention provides a preparation method of tri (hydroxyalkyl) methyl amine, which has the characteristics that the preparation method comprises the following reaction steps:
in the above formula, PG is an amino protecting group, x and y are independently selected from any integer between 0 and 5,
Step 1, sequentially reacting a compound 4 with ozone and a reducing agent to obtain a compound 5;
Step 2, reacting the compound 5 with an amino protecting group removal reagent to obtain a compound 6.
In one embodiment of the invention, x=y=0 or 1.
In one embodiment of the invention, the reducing agent is a metal complex hydrogen compound. The metal complex hydrogen compound is selected from any one or more of sodium borohydride, potassium borohydride, lithium aluminum hydride and sodium thiosulfate.
In one embodiment of the invention, the amino protecting group is selected from the group consisting of benzyloxycarbonyl, t-butyloxycarbonyl, fluorenylmethoxycarbonyl, p-methoxybenzyl, benzyl, trityl, p-toluenesulfonyl, phthaloyl, allyloxycarbonyl.
In one embodiment of the invention, in the step 1, the compound 4 is mixed with the organic solvent 1 and the alkali reagent, the temperature is controlled at-50 ℃ to-80 ℃ (specifically, the temperature is selected to be-78 ℃), ozone is introduced for reaction, the temperature is returned to 0 ℃ to 10 ℃ (specifically, the temperature is selected to be 0 ℃), the organic solvent 2 and the reducing agent are added, and then the temperature is raised to the room temperature for reaction, so that the compound 5 is obtained.
In one embodiment of the present invention, the concentration condition of the compound 4 with respect to the organic solvent 1 is 0.2 to 0.5mol/L, and specifically, 0.35mol/L is selected.
In one embodiment of the present invention, the organic solvent 1 and the organic solvent 2 are respectively and independently selected from one or two of methanol and dichloromethane. Wherein, the organic solvent 1 and the organic solvent 2 are preferably the combination of methanol and methylene dichloride, and the volume ratio of the two is 1:1.
In one embodiment of the present invention, the volume ratio of the organic solvent 1 to the organic solvent 2 is 2:1.
In one embodiment of the invention, the alkaline agent is selected from any one or more of sodium bicarbonate, sodium carbonate or sodium hydroxide. The molar ratio of the alkali reagent to the compound 4 is (2-4): 1.
In one embodiment of the invention, the molar ratio of the reducing agent to compound 4 (8-15): 1. And particularly, the ratio of the components is 10:1.
In one embodiment of the present invention, when the amino protecting group is benzyloxycarbonyl or benzyl, compound 5 is dissolved in organic solvent 3 in step 2, followed by a heating reaction with Pd/C/hydrogen as the amino deprotection reagent.
In one embodiment of the present invention, the organic solvent 3 is an alcohol solvent, preferably methanol and/or ethanol.
The invention provides an intermediate for synthesizing tri (hydroxyalkyl) methyl amine, the structure of which is shown as formula 4:
In the above formula, PG is an amino protecting group, and x and y are independently selected from any integer between 0 and 5.
In one embodiment of the invention, PG is carbobenzoxy or t-butoxycarbonyl.
In one embodiment of the present invention, x=y=1.
In one embodiment of the present invention, the preparation process of the above intermediate includes:
Wherein X is halogen (Br, cl, I), X and y are independently selected from any integer between 0 and 5;
A. firstly, reacting a compound 1 with a compound 2 to obtain a compound 3;
B. compound 3 is then reacted with an amino protecting reagent to afford compound 4.
In one embodiment of the present invention, compound 2 is dispersed in tetrahydrofuran solution, cooled to-10-5 ℃, then diethyl ether solution of compound 1 is added dropwise, and then the mixture is heated to 40-60 ℃ for reaction for a period of time to obtain compound 3.
In one embodiment of the present invention, after the reaction is completed, the reaction solution is mixed with a saturated aqueous ammonium chloride solution, then the mixture is subjected to extraction by adjusting the pH to 3 to 4, and the organic phase is collected and then concentrated to give compound 3.
In one embodiment of the invention, the molar ratio of compound 1 to compound 2 in step A is 1 (2-3).
In one embodiment of the invention, the concentration of the diethyl ether solution of compound 1 in step A is between 0.3 and 1.0g/mL. Specifically, 0.5g/mL is selected.
In one embodiment of the invention, the concentration of compound 2 dispersed in the tetrahydrofuran solution in step A is 0.8 to 1.5mol/L, specifically 1.0mol/L.
In one embodiment of the present invention, compound 3 is dispersed in a solvent, and then a base reagent and an amino protecting reagent are added to the mixture to react with each other in step B.
In one embodiment of the invention, the molar ratio of the base reagent, amino protecting reagent to compound 3 is (2-4): 1-2): 1.
In one embodiment of the present invention, the base reagent is diisopropylethylamine, triethylamine. The amino protecting reagent is selected from any one of benzyl chloroformate, tert-butyl chloroformate and di-tert-butyl dicarbonate.
The invention provides an intermediate for synthesizing tri (hydroxyalkyl) methyl amine, the structure of which is shown as formula 5:
In the above formula, PG is an amino protecting group, and x and y are independently selected from any integer between 1 and 5.
In one embodiment of the invention, PG is carbobenzoxy or t-butoxycarbonyl.
In one embodiment of the present invention, x=y=1.
Effects and effects of the invention
According to the preparation method of the tri (hydroxyalkyl) methyl amine, because the terminal alkenyl compound is treated by using the ozone/reducing agent, the terminal alkenyl compound can be converted into hydroxyl with one less carbon atom, so the preparation method provided by the invention is simpler, more suitable for industrialization, and more universal in comparison with the prior art, a series of tri (hydroxyalkyl) methyl amines can be obtained by only changing the carbon chain length of the raw materials.
Drawings
FIG. 1 is a high performance liquid chromatogram of compound 6a produced in example 4;
FIG. 2 is a nuclear magnetic resonance hydrogen spectrum of the compound 6a produced in example 4.
Detailed Description
In order to make the technical means, the creation features, the achievement of the purpose and the effect of the present invention easy to understand, the present invention is specifically described below with reference to the embodiments and the drawings.
In the examples below, each of the raw materials was a commercially available product unless otherwise specified.
Example 1]
Process for the preparation of Compound 3a
This example provides a process for the preparation of compound 3a, having the following formula:
The method comprises the following steps:
Under the protection of nitrogen, 3.36L of tetrahydrofuran solution (1.0 mol/L) of the compound 2a is added into a reaction vessel, the temperature is reduced to 0 ℃, 200mL of diethyl ether solution (500 g/L,1.49 mol) of the compound 1a is dripped into the reaction vessel, after the dripping is finished, the temperature is raised to 45 ℃ and the reaction is stirred for 4 hours, TLC detection reaction is completed, the reaction solution is poured into 5L of saturated ammonium chloride aqueous solution, 2mol/L of hydrochloric acid aqueous solution is used for adjusting the pH value to 3, the organic phase is extracted, anhydrous sodium sulfate is dried and concentrated under reduced pressure, 158.5g of the compound 3a is obtained, the yield is 70.3 percent, the oil is light yellow, no further purification is needed, and the reaction solution can be directly used in the next step.
1H NMR(400MHz,Chloroform-d)δ5.79(ddt,J=17.5,10.2,7.5Hz,3H),5.14–4.96(m,6H),2.06(d,J=7.5Hz,6H).
Example 2 ]
Process for the preparation of Compound 4a
This example provides a process for the preparation of compound 4a, having the following formula:
The method comprises the following steps:
150g of compound 3a (0.99 mol,1.0 eq) were dissolved in 2L of methylene chloride, 385g of diisopropylethylamine (2.98 mol,3.0 eq) and 280g of benzyl chloroformate (1.64 mol,1.66 eq) were added in this order and reacted under stirring at 25℃for 3h. TLC detection showed that the reaction was complete, and 750mL of 2mol/L aqueous hydrochloric acid was added to extract, the organic phase was taken, washed with saturated brine, dried over anhydrous sodium sulfate, concentrated under pressure, and column-chromatographed to give 180.0g of compound 4a, yield 63.7% as a yellow liquid.
LCMS:m/z(ESI),[M+H]+=286.
1H NMR(400MHz,DMSO-d6)δ7.39–7.28(m,5H),6.90(s,1H),5.81–5.67(m,3H),5.11–4.97(m,8H),2.32(d,J=7.2Hz,6H).
< Example 3-1>
Process for preparing compound 5a
This example provides a process for the preparation of compound 5a, having the following formula:
The method comprises the following steps:
200g of compound 4a (0.70 mol,1.0 eq) and 1L of methanol were added to 1L of methylene chloride, 176.4g of sodium hydrogencarbonate (2.10 mol,3.0 eq) were added, the temperature was lowered to-78 ℃, ozone was introduced (introduction rate 1L/min, continuous introduction was carried out for 10 hours), the reaction solution was blue, and the reaction was stirred for 10 hours (from the time of introduction of ozone).
The resulting reaction solution was warmed to 0℃and 0.5L of methanol and 0.5L of methylene chloride were added thereto, 266g of sodium borohydride (7.0 mol,10.0 eq) was added thereto, and the temperature was raised to 25℃and the reaction was stirred for 2 hours.
LCMS detection reaction was complete, ice water bath was cooled to 0 ℃, pH was adjusted to 5 using 4mol/L aqueous hydrochloric acid, filtered using celite, filtrate was concentrated, column chromatography to give 172g of compound 5a, yield 82.6% as colorless liquid.
LCMS:m/z(ESI),[M+H]+=298.
1H NMR(400MHz,Methanol-d4)δ7.36–7.29(m,5H),5.01(s,2H),3.65(t,J=7.1Hz,6H),1.98(t,J=7.2Hz,6H).
< Example 3-2>
Process for preparing compound 5a
This example provides a process for the preparation of compound 5a, having the following formula:
The method comprises the following steps:
200g of Compound 4a (0.70 mol,1.0 eq) was added to 2L of dichloromethane, 176.4g of sodium bicarbonate (2.10 mol,3.0 eq) was added, the temperature was lowered to-78℃and ozone was introduced (at a rate of 1L/min, 10h continued), the reaction mixture was blue, and the reaction was stirred for 10h (from the time when ozone was introduced).
The resulting reaction solution was warmed to 0℃and 1L of methanol was added thereto, 266g of sodium borohydride (7.0 mol,10.0 eq) was added thereto, and the temperature was raised to 25℃and the reaction was stirred for 2 hours.
LCMS detection reaction was complete, ice water bath was cooled to 0 ℃, pH was adjusted to 5 using 4mol/L aqueous hydrochloric acid, filtered using celite, the filtrate was concentrated, column chromatography to give 144.7g of compound 5a, yield 69.5% as colorless liquid.
Example 4 ]
Process for the preparation of Compound 6a
This example provides a method for preparing compound 6a, which has the following reaction formula:
The method comprises the following steps:
70g of compound 5a was dissolved in 700mL of methanol, 7g of 10wt% palladium on carbon catalyst was added to replace hydrogen, the reaction vessel was allowed to be in a hydrogen atmosphere, heated to 40℃and stirred for reaction for 5 hours. TLC monitoring showed the reaction was complete, filtered through celite, and concentrated under reduced pressure to remove the solvent to give 31.5g of compound 6a in 82% yield, 99.9% purity as a white solid.
The high performance liquid chromatogram and the hydrogen chromatogram of the compound 6a are shown in figures 1-2.
HPLC (ELSD) rt=1.844 min with HPLC purity 99.9%.
1H NMR(400MHz,DMSO-d6)δ3.87(s,5H),3.52(t,J=6.9Hz,6H),1.51(t,J=6.9Hz,6H).
Effects and effects of the examples
According to the preparation method of the tri (hydroxyalkyl) methyl amine, which is related to the embodiment, because the terminal alkenyl compound is treated by using ozone/reducing agent, the terminal alkenyl compound can be converted into hydroxyl groups with one less carbon atom, so the preparation method provided by the invention is simpler, more suitable for industrialization, and more universal compared with the prior art, a series of tri (hydroxyalkyl) methyl amines can be obtained by only changing the carbon chain length of the raw materials.
Further, in the above embodiment, after the ozonolysis reaction, the peroxide formed by the reaction is not treated by the traditional reducing agents such as zinc powder/acid, trimethyl phosphite and the like, but sodium borohydride is creatively selected, so that the peroxide formed after the ozonolysis is directly converted into hydroxyl groups instead of aldehyde groups, and the reaction steps are greatly saved.
Further, since the above examples selected methanol and methylene chloride as mixed solvents in the steps of ozonolysis and subsequent reduction reactions, higher yields were obtained than with a single solvent.
The above examples are provided as preferred embodiments of the present invention and are not intended to limit the scope of the invention, nor the order of execution of the steps described. The present invention is obviously modified by a person skilled in the art in combination with the prior common general knowledge, and falls within the scope of protection defined by the claims of the present invention.

Claims (7)

CN202311483348.6A2023-11-082023-11-08Preparation method and intermediate of tri (hydroxyalkyl) methylamineActiveCN117603064B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202311483348.6ACN117603064B (en)2023-11-082023-11-08Preparation method and intermediate of tri (hydroxyalkyl) methylamine

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202311483348.6ACN117603064B (en)2023-11-082023-11-08Preparation method and intermediate of tri (hydroxyalkyl) methylamine

Publications (2)

Publication NumberPublication Date
CN117603064A CN117603064A (en)2024-02-27
CN117603064Btrue CN117603064B (en)2025-09-16

Family

ID=89955376

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202311483348.6AActiveCN117603064B (en)2023-11-082023-11-08Preparation method and intermediate of tri (hydroxyalkyl) methylamine

Country Status (1)

CountryLink
CN (1)CN117603064B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
RU2397975C1 (en)*2008-11-272010-08-27Андрей Александрович ИващенкоSubstituted 2-(5-hydroxy-2-methyl-1h-indol-3-yl)acetic acids and esters thereof, antiviral agent, pharmaceutical composition, medicinal agent, method of treating viral diseases
CN106432330B (en)*2015-08-112019-02-01天津科伦药物研究有限公司The midbody compound and its preparation method and application of LB80380 drug
CA3207753A1 (en)*2021-02-102022-08-18Jessica DETERLINGCompounds, compositions, and methods of using thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAS:2626517-63-4等;无;《REGISTRY DATABASE》;20210322;第1-4页*

Also Published As

Publication numberPublication date
CN117603064A (en)2024-02-27

Similar Documents

PublicationPublication DateTitle
CN114805314A (en)Synthesis method of Ensaitevir
CN116217522B (en)Chiral purification method of key intermediate of GLP-1 receptor agonist
TW202210477A (en)Stereoselective synthesis of intermediate for preparation of heterocyclic compound
CN106831441B (en)A kind of preparation method of cinacalcet hydrochloride
CN117603064B (en)Preparation method and intermediate of tri (hydroxyalkyl) methylamine
CN110343056B (en)Preparation method of N-tert-butyloxycarbonyl-N-methyl-2-amino-4, 4-dimethylpentanoic acid
JPH03169839A (en)Production of quarternary ammonium salt
CN110668951B (en)Synthesis process of selegiline hydrochloride
CN116162057B (en)Preparation method of 5-sulfonyl-1, 4 dihydropyridine compound
US5637704A (en)Preparation of hydroxyoxaalkylmelamines
CN108117564B (en)Process method for preparing cryptate 222
CN114751836B (en)Synthesis method and intermediate of 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline
CN116574018A (en)Preparation method of methoxamine hydrochloride
CN112679448B (en)Preparation method of N- (2-aminoethyl) morpholine
CN115947675A (en)Rasagiline intermediate and preparation method and application thereof
US20130137900A1 (en)Novel method of preparing secondary amine compound using microflow reactor
CN112824381B (en) A kind of preparation method of piperidine amine
CN110818619B (en)Synthetic method of N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide
CN115010656A (en)Preparation method of 5-acetyl-2-bromopyridine
CN102093292A (en)Method for synthesizing DL-alpha-aminocaprolactam
CN112194598A (en)Process for the preparation of 3- (tert-butoxycarbonyl-ethoxycarbonylmethyl-amino) -propanoate
CN113999125A (en)Preparation method of 2-methyl ethylamine
KR20220048950A (en)Method of preparing intermediate for synthesizing sphingosine-1-phosphate receptor agonist
CN115925615B (en) A method for preparing optically pure 2-methylpiperidin-5-amine
US4507499A (en)N-(4-Hydroxybenzyl)-3,4,5-trimethoxybenzamide and method for producing trimethobenzamide chlorohydrate

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
CB02Change of applicant information
CB02Change of applicant information

Country or region after:China

Address after:Room 201, No. 5, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, 200000

Applicant after:Shanghai Lingkai Technology Co.,Ltd.

Address before:201321 Building 5, No. 3399, Kangxin Road, Pudong New Area, Shanghai

Applicant before:SHANGHAI LINKCHEM TECHNOLOGY Co.,Ltd.

Country or region before:China

GR01Patent grant
GR01Patent grant

[8]ページ先頭

©2009-2025 Movatter.jp